The Effect of Shinbaro and Bee Venom Pharmacopuncture in Treating Lumbar Disc Herniations

Article information

J Korean Acupunct Moxib Soc. 2013;30(5):41-50
Publication date (electronic) : 2013 December 20
doi : https://doi.org/10.13045/acupunct.2013044
Department of Acupuncture & Moxibustion Medicine, Wonkwang University Oriental Medicine Hospital
*Corresponding author : Department of Acupuncture & Moxibustion Medicine, Wonkwang University Oriental Medicine Hospital, 895, Muwang-ro, Iksan-si, Jeollabuk-do, 570-754, Republic of Korea, Tel : +82-63-859-2812 E-mail : choandle@hanmail.net
Received 2013 November 11; Revised 2013 November 26; Accepted 2013 November 29.

Abstract

Objectives:

This study was performed to compare the effects of Shinbaro pharmacopuncture therapy and bee venom pharmacopuncture therapy in lumbar disc herniation

Methods:

We compared treatment efficacy of 12 patients with Shinbaro pharmacopuncture therapy and 10 patients with bee venom pharmacopuncture therapy, all of whom were diagnosed with lumbar disc herniation using computed tomography(CT) or magnetic resonance imaging(MRI). We performed a retrospective comparison and analysis during the course of 21 days since admission. To evaluate the treatment efficacy, we recorded the temperatures of the opposite back, hip, and legs with visual analog scale(VAS, back and legs), pain rating scale(PRS), Oswestry disability index(ODI) and digital infrared thermal imaging(DITI) based on patients’ medical records.

Results:

Both treatments were effective in reducing pain and improving functions for lumbar disc herniation patients in terms of VAS, PRS, ODI, DITI. Shinbaro pharmacopuncture group showed slightly better results than the bee venom pharmacopuncture group, but the difference was not significant.

Conclusions:

For the treatment of lumbar disc herniation, it is suggested that Shinbaro pharmacopuncture therapy is thought to be as effective as bee venom pharmacopuncture therapy without side effects, although further study would be necessary.

Fig. 1.

Changes on VAS of low back pain

Fig. 2.

Changes on VAS of sciatica

Fig. 3.

Changes on PRS

Fig. 4.

Changes on ODI

Fig. 5.

Changes on ΔT by DITI

General Characteristics between Group A and Group B

Changes on VAS, ODI, PRS, ΔT between Before and After in Group A*

Changes on VAS, ODI, PRS, ΔT between Before and After in Group B*

Comparision on VAS, ODI, PRS, ΔT between Group A and Group B

References

1. Korean Acupuncture and Moxibustion Medicine Medicine Society Textbook Compilation Committee. The Acupuncture and Moxibustion Medicine 1st. editionth ed. Paju: Jipmoondang; 2012. p. 200p. 250–1. p. 512.
2. Korean Orthopaedic Association. Orthopaedics 6th editionth ed. Seoul: Newest Medicine Company; 2006. p. 623–5.
3. Shvartzman L, Weingarten E, Sherry H, Levin S, Persaud A. Cost- effectiveness analysis of extended conse-rvative therapy versus surgical intervention in the management of herniated lumbar intervertebral disc. Spine 1992;17(2):176–82.
4. Saal JA, Saal JS. Nonoperative treatment of herniated lumbar inter-vertebral disc with radiculopathy: an outcom study. Spine 1989;14(4):431–7.
5. Cho HJ, Sul JU, Shin MS. Research Trends on the Treatment of Lumbar Herniated Intervertebral Disc in Korean Medicine. Korean Journal of Acupuncture 2012;29(4):501–18.
6. Jun BC, Kim ES, Kim DS, Kim TH, Kim JY. Effectiveness of ShinBaro Pharm- acopuncture on Lumbar Spinal Herniated Intervertebral Disc: A Randomized Controlled Trial. The Journal of Korea CHUNA Manual Medicine for Spine & Nerves 2011;6(2):109–19.
7. Sin HY, Lee SM, Kim JH, et al. Comparative study of effects on intracutaneous bee venom pharm-acopuncture and intramuscular bee venom pharm-acopuncture in lumbar disc herniation. The Journal of Korean Acupuncture and Moxibustion Society 2011;28(3):1–11.
8. Lee SH, Lang MW, Lee H, Lee SY. Effectiveness of Bee-venom Acpuncture and Ouhyul Herbal Acpuncture in Herniation of Nucleus Pulposus- comparison with Acpuncture Therapy Only. The Journal of Korean Acupuncture and Moxibustion Society 2007;24(5):197–205.
9. Yu SM, Lee JY, Gwan GL, Lee HS. Comparative study of acupuncture, bee venom acupuncture and bee venom pharmacopuncture on the treatment of herniation of nucleus pulpous. The Journal of Korean Acupuncture and Moxibustion Society 2006;23(5):39–54.
10. Chung WS, Lee JS, Chung SH, Kim SS. The effect of Bee Venom Acupuncture on Patient with Herniation of Nucleus Pulposus of Lumbar Spine. The Journal of The Korean Academy of Oriental Rehabilitation Medicine 2003;13(2):89–101.
11. Hong JT, Park HJ, Lee SH, et al. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis & Rheumatism 2004;50(11):3504–15.
12. Kim DW, Kim Y, Shin JS. The clinical effect of Cheongpa-jeon on the group of patients who were treated under conservative remedies for LBP. The Journal of Korea CHUNA Manual Medicine 2004;5(1):85–92.
13. Kim H, Kim CH, Joen SI. Clinical Value of a New Self Assessment Method of Pain. Korean Academy of Rehabilitation Medicine 1998;22(2):305–11.
14. Shin SU, Chung SH, Lee JS, Shin HD, Kim SS. The Study for Clinical Measurement of Pain. Dongguk J The Institute of Oriental Medicine 2000;8(2):25–46.
15. Fairbank JCT, Davia J, Couper J, O’Brien J. The Oswestry Disability Questionnaire. Physiotheraphy 1980;66:271–3.
16. Koh KH, Park SY, Choi HK, et al. Clinical study on treatment of HIVD of lumbar spine using Scolopendrid herbal acupuncture. The Journal of Pharmacopuncture 2002;19(3):192–206.
17. Choi YT, Choi IS, Kang SK, Park DS. Clinical study of Acupuncture treatment for Low Back Pain. Theses Collection. Kyoung Hee univ 1979;9:883–902.
18. The Korean Neurosurgical Society. Neurosurgery 3rd editionth ed. Seoul: Joongang Moonhwa company; 2005. p. 287–95.
19. Yu S, Hanughton VM, Sether LA, Wagner M. Anulus fibrosus in bulging intervertebral disc. Radiology 1988;169(3):761–3.
20. The Korean Academy of Oriental Rehabilitation Medicine. Oriental Rehabilitation Medicine 2nd editionth ed. Seoul: Koonja publishing company; 2006. p. 59–60.
21. Suk SI. Textbook of spinal surgery Seoul: Newest Medicine Company; 2004. p. 218–52.
22. Kraemer J. Presidental address: natural course and prognosis of intervertebral disc disease. Spine 1995;20(6):635–9.
23. Weber H. Lumbar disc herniation: A controlled prospective study with ten years of observation. Spine 1983;8(2):131–40.
24. Chung HJ, Lee HS, Shin JS, et al. Modulation of acute and chronic inflammatory processes by a traditional medicine preparation GCSB-5 both in vitro and in vivo animal models. Journal of Ethnopharmacology 2010;130(3):450–9.
25. Kim TH, Yoon SJ, Lee WC, et al. Protective effect of GCSB-5, an herbal preparation, against peripheral nerve injury in rats. Journal of Ethnopharmacology 2011;136(2):297–304.
26. Ro Park HR, Lee SH, Choo JY, et al. The Comparative Study on the Effect of ShinBaro Pharmacopuncture Treatment and Bee Venom Pharmacopuncture Treatment of Patient with Spondylo- listhesis. The Journal of Korea CHUNA Manual Medicine for Spine & Nerves 2012;7(2):53–61.
27. Uematsu S, Edwin DH, Jankel WR, Kozikowski J, Trattner M. Quantification of thermal asymmetry: Part 1: Normal values and repro- ducibility. Journal of neurosurgery 1998;69(4):552–5.
28. Pochaczevsky R, Wexler CE, Meyers PH. Liquid crystal thermography of the spine and extremities. Its value in the diagnosis of spinal root syndromes. Journal of Neurosurgery 1988;69(4):556–61.

Article information Continued

Fig. 1.

Changes on VAS of low back pain

Fig. 2.

Changes on VAS of sciatica

Fig. 3.

Changes on PRS

Fig. 4.

Changes on ODI

Fig. 5.

Changes on ΔT by DITI

Table 1.

General Characteristics between Group A and Group B

Group A* Group B p-value
Total 12 10
Gender Male 4 2 0.646
Female 8 8
Age(years) 44.42±14.65 48.10±10.69 0.628§
Symptom duraion Acute 5 5 0.870
Subacute 3 3
Chronic 4 2
Herniated type Bulging 4 2 0.813
Protrusion 5 5
Extrusion 2 1
Mixed 1 2
Scales at baseline VAS of low back pain 4.50±2.32 4.70±2.36 0.872§
VAS of sciatica 5.29±2.12 5.05±1.70 0.771§
PRS 71.67±24.34 80.90±26.99 0.674§
ODI 51.88±21.74 49.02±15.05 0.923§

Plus-minus values are means±SD.

*:

treatment with Shinbaro pharmacopuncture.

† :

treatment with Bee venom pharmacopuncture.

‡ :

calculated by Fisher’s exact test.

§ :

calculated by Mann-Whitney U test.

Table 2.

Changes on VAS, ODI, PRS, ΔT between Before and After in Group A*

Before After p-value
VAS of low back pain 4.50±2.32 1.51±1.47 0.001
VAS of Sciatica 5.29±2.12 1.23±1.20 0.000
PRS 71.67±24.34 26.08±20.27 0.000
ODI 51.88±21.74 27.41±19.51 0.000
ΔT of PSIS(by DITI) 0.48±0.26 0.16±0.19 0.006
ΔT of GB30(by DITI) 0.65±0.27 0.25±0.25 0.003
ΔT of leg(by DITI) 0.47±0.22 0.15±0.24 0.003

Plus-minus values are means±SD.

*:

treatment with Shinbaro pharmacopuncture.

† :

calculated by Wilcoxon signed ranks test.

‡ :

n=11.

Table 3.

Changes on VAS, ODI, PRS, ΔT between Before and After in Group B*

Before After p-value
VAS of low back pain 4.70±2.36 1.90±1.31 0.004
VAS of Sciatica 5.05±1.70 2.01±1.75 0.002
PRS 80.90±26.99 37.70±22.41 0.002
ODI 49.02±15.05 29.28±13.44 0.002
ΔT of PSIS(by DITI) 0.24±0.46 0.06±0.35 0.212
ΔT of GB30(by DITI) 0.54±0.22 0.07±0.36 0.012
ΔT of leg(by DITI) 0.50±0.31 0.15±0.30 0.024

Plus-minus values are means±SD.

*:

treatment with bee venom pharmacopuncture.

† :

calculated by Wilcoxon signed ranks test.

Table 4.

Comparision on VAS, ODI, PRS, ΔT between Group A and Group B

Group A* Group B p-value
VAS of low back pain 2.99±2.05 2.80±1.42 0.974
VAS of Sciatica 4.06±1.89 3.04±1.10 0.180
PRS 45.58±20.68 43.2±21.41 0.314
ODI 24.46±10.12 19.74±7.55 0.872
ΔT of PSIS(by DITI)§ 0.32±0.27 0.18±0.41 0.282
ΔT of GB30(by DITI)§ 0.41±0.24 0.47±0.38 0.387
ΔT of leg(by DITI)§ 0.32±0.24 0.35±0.36 0.973

Plus-minus values are means±SD.

*:

treatment with Shinbaro pharmacopuncture.

† :

treatment with Bee venom pharmacopuncture.

‡ :

calculated by Mann-Whitney U test.

§ :

group A(n=11), group B(n=10).